These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry. Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133 [TBL] [Abstract][Full Text] [Related]
10. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097 [TBL] [Abstract][Full Text] [Related]
12. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation. Uto Y; Ogata T; Kiyotsuka Y; Miyazawa Y; Ueno Y; Kurata H; Deguchi T; Yamada M; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Konishi M; Kurikawa N; Kono K; Osumi J Bioorg Med Chem Lett; 2009 Aug; 19(15):4159-66. PubMed ID: 19541482 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents. Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972 [TBL] [Abstract][Full Text] [Related]
14. Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Deng Y; Yang Z; Shipps GW; Lo SM; West R; Hwa J; Zheng S; Farley C; Lachowicz J; van Heek M; Bass AS; Sinha DP; Mahon CR; Cartwright ME Bioorg Med Chem Lett; 2013 Feb; 23(3):791-6. PubMed ID: 23265904 [TBL] [Abstract][Full Text] [Related]
15. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs. Yang SM; Tang Y; Rano T; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Lang W; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV Bioorg Med Chem Lett; 2014 Mar; 24(5):1437-41. PubMed ID: 24405703 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice. Zhang L; Chen J; Ning M; Zou Q; Leng Y; Shen J Bioorg Med Chem Lett; 2012 Apr; 22(8):2748-52. PubMed ID: 22440625 [TBL] [Abstract][Full Text] [Related]